Biotechnology Companies By Held By Institutions

Shares Owned By Institutions
Shares Owned By InstitutionsEfficiencyMarket RiskExp Return
1CLDX Celldex Therapeutics
100.0
(0.11)
 3.15 
(0.33)
2NKTX Nkarta Inc
100.0
(0.01)
 7.16 
(0.06)
3PTCT PTC Therapeutics
99.99
 0.13 
 2.58 
 0.34 
4AVTE Aerovate Therapeutics
99.99
(0.04)
 1.79 
(0.07)
5VRDN Viridian Therapeutics
99.88
(0.13)
 3.24 
(0.42)
6COGT Cogent Biosciences
99.85
(0.04)
 4.08 
(0.17)
7ZYME Zymeworks Common Stock
99.82
(0.06)
 3.33 
(0.19)
8XENE Xenon Pharmaceuticals
99.63
(0.08)
 2.00 
(0.17)
9PEPG PepGen
99.62
(0.04)
 14.86 
(0.54)
10DVAX Dynavax Technologies
99.6
 0.07 
 1.51 
 0.11 
11EWTX Edgewise Therapeutics
99.54
(0.07)
 3.57 
(0.26)
12PRAX Praxis Precision Medicines
99.54
(0.11)
 7.17 
(0.81)
13ATXS Astria Therapeutics
99.53
(0.16)
 3.46 
(0.57)
14TNGX Tango Therapeutics
99.51
(0.20)
 5.10 
(1.03)
15PCVX Vaxcyte
99.5
(0.06)
 3.25 
(0.19)
16ACAD ACADIA Pharmaceuticals
99.46
 0.03 
 2.82 
 0.07 
17RYTM Rhythm Pharmaceuticals
99.46
(0.02)
 2.64 
(0.05)
18ANNX Annexon
99.42
(0.25)
 5.01 
(1.25)
19CYTK Cytokinetics
99.41
(0.03)
 3.38 
(0.10)
20TVTX Travere Therapeutics
99.38
 0.09 
 3.92 
 0.35 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen. Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.